Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Plos One|September 29, 2021
Characterization of a dual media system for culturing primary normal and Fuchs endothelial corneal dystrophy (FECD) endothelial cellsTommy A Rinkoski, Cindy K Bahler, Johann M Pacheco, et al.
Investigative Ophthalmology & Visual Science|January 25, 2017
Trinucleotide Repeat Expansion in the Transcription Factor 4 (TCF4) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal DystrophyEric D Wieben, Ross A Aleff, Xiaojia Tang, et al.
Investigative Ophthalmology & Visual Science|January 14, 2021
Disease Expression and Familial Transmission of Fuchs Endothelial Corneal Dystrophy With and Without CTG18.1 ExpansionTimothy T Xu, Yi-Ju Li, Natalie A Afshari, et al.
Cornea|January 22, 2019
Comparison of Donor Cornea Endothelial Cell Density Determined by Eye Banks and by a Central Reading Center in the Cornea Preservation Time StudyBeth Ann Benetz, Christopher G Stoeger, Sanjay V Patel, et al.
British Journal of Haematology|June 13, 2022
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myelomaJithma P Abeykoon, Julia Vaxman, Sanjay V Patel, et al.
JAMA Ophthalmology|October 17, 2025
Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical TrialJonathan H Lass, Beth Ann Benetz, David D Verdier, et al.
JAMA Ophthalmology|November 12, 2017
Corneal Endothelial Cell Loss 3 Years After Successful Descemet Stripping Automated Endothelial Keratoplasty in the Cornea Preservation Time Study: A Randomized Clinical TrialJonathan Lass, Beth Ann Benetz, David D Verdier, et al.
Ophthalmology|February 22, 2019
Postoperative Endothelial Cell Density Is Associated with Late Endothelial Graft Failure after Descemet Stripping Automated Endothelial KeratoplastySanjay V Patel, Jonathan H Lass, Beth Ann Benetz, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple MyelomaMatthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
JAMA Ophthalmology|October 17, 2025
Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical TrialFrancis W Price, Loretta B Szczotka-Flynn, Marianne O Price, et al.
Pageof 15